FindTrial
Sign In

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date

3 trials

Sponsors

Pheno Therapeutics Limited, NRG Therapeutics Ltd, Lundbeck (Denmark)

Conditions

Assessment of blood/brain distribution of an IMP for Neurodegenerative Disease, specifically ALS (Amyotrophic Lateral Sclerosis) in healthy adults Nervous System DiseasesThis is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date Other

Phase 1

Deferred registration: Fortrea code: 776181
RecruitingISRCTN72930441
Lundbeck (Denmark)This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date Other
Start: 2026-07-15Target: 32Updated: 2026-07-20
Deferred Registration: Quotient Sciences Code: QSC302324
Active, not recruitingISRCTN13656987
Pheno Therapeutics LimitedThis is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date Other
Start: 2026-11-17Target: 84Updated: 2026-08-03
Deferred registration: NRG5051-102
RecruitingISRCTN15580445
NRG Therapeutics LtdAssessment of blood/brain distribution of an IMP for Neurodegenerative Disease, specifically ALS (Amyotrophic Lateral Sclerosis) in healthy adults Nervous System Diseases
Start: 2026-08-04Target: 8Updated: 2026-08-31